<DOC>
	<DOCNO>NCT00426296</DOCNO>
	<brief_summary>SHARE : Simple HAART Abacavir , Reyataz , Epivir</brief_summary>
	<brief_title>SHARE : Simple HAART With Abacavir , Reyataz , Epivir</brief_title>
	<detailed_description>Open-label , multicenter study ABC/3TC + ATV subject complete least 24 week treatment ABC/3TC+ATV/RTV first line regimen plasma HIV-1 RNA &lt; 50 copies/mL entry</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<criteria>Currently take abacavir/lamivudine ( Epzicom ) combination atazanavir ( Reyataz ) boost ritonavir ( Norvir ) first antiretroviral regimen Viral load &lt; 50 copies/ml Viral load &gt; 50 copies/ml Having take one antiretroviral regimen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>HIV</keyword>
	<keyword>Reyataz</keyword>
	<keyword>atazanavir</keyword>
	<keyword>Norvir</keyword>
	<keyword>ritonavir</keyword>
	<keyword>Boosted</keyword>
	<keyword>Lipodystrophy</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>